Medical Facilities Corporation

TSX:DR.TO

Medical - Care Facilities

Healthcare
$17.43 +1.01%

+$0.18 today

Market cap
$282.59M
Beta
0.34
P/E (TTM)
8.7
EPS (TTM)
$1.47
Dividend yield
2.00%
52W Low $13.59High $18.79

Volume 0.04M

Average 0.02M

DR.TO Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Medical Facilities CorporationTSX: DR.TO

Net Margin · Q1 FY2026 · quarter ended Mar 2026

Net margin widens to 11.8%

Net margin was 11.8% in Q1 FY2026, up 7.2 pp from a year earlier. On a trailing-twelve-month basis it was 8.5%, down 16.2 pp year over year. Over 3 fiscal years it widened by 9.2 pp.

Context

  • Net margin widened in 2 of the last 3 fiscal years.

What to watch

Whether net margin reaches the consensus estimate from 1 analysts of 14.9% for the fiscal year ending Dec 2026, up from 8.2% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
11.8%+4.6 pp QoQ
Last fiscal yearDec 2025
8.2%-14.0 pp YoY
LTMMar 2026
8.5%-16.2 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+7.2 pp-0.5 pp-7.7 pp
1 year-14.0 pp+6.8 pp+20.8 pp
3 years+9.2 pp+4.7 pp-4.5 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
8.2%
Year-over-year change
-14.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How DR.TO compares with its peers on the latest reported figures

  • DR.TO's LTM Mar 2026 net margin of 8.5% is the 2nd highest of the 8 companies compared; the peer median is -17.2%.
  • Its year-over-year change of -16.2 pp is the 7th highest of 8, against a peer median of +8.3 pp.
  • Over three fiscal years its change of +9.2 pp compares with a peer median of +165.1 pp.
DR.TO Competitors Peer median
Net Margin for DR.TO and competitors
Company Period LTM level YoY 3-year change
XLY.TOAuxly Cannabis Group Inc.LTM Mar 202620.9% +4.2 pp+165.5 pp
DR.TOMedical Facilities CorporationLTM Mar 20268.5% -16.2 pp+9.2 pp
CRRX.TOCareRx CorporationLTM Mar 20267.2% +8.3 pp+16.1 pp
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-9.2% -17.9 pp—
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026-17.2% +29.5 pp+1532.6 pp
TSND.TOTerrAscend Corp.LTM Mar 2026-31.2% -4.4 pp+93.3 pp
WEED.TOCanopy Growth CorporationLTM Mar 2026-84.8% +137.6 pp+891.3 pp
PRN.TOProfound Medical Corp.LTM Mar 2026-206.9% +77.0 pp+164.7 pp
EPRX.TOEupraxia Pharmaceuticals Inc.FY2025— ——
Peer median (excluding DR.TO) -17.2%+8.3 pp+165.1 pp

Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue398.63M424.55M445.58M331.53M258.62M
Cost of Revenue130.03M143.93M148.9M111.65M160.42M
Gross Profit268.61M280.63M296.68M219.88M98.2M
Gross Margin67.4%66.1%66.6%66.3%38.0%
Research & Development00000
Selling, General & Admin177.58M198.21M151.73M151.12M119.23M
Operating Expenses191.25M245.69M229.57M158.24M50.72M
Depreciation & Amortization26.77M20.76M21.54M19.37M11.94M
EBITDA103.4M51.15M72.43M82.57M59.41M
EBITDA Margin25.9%12.0%16.3%24.9%23.0%
Operating Income77.36M34.94M67.11M61.64M47.47M
Operating Margin19.4%8.2%15.1%18.6%18.4%
Interest Income76K8.54M717K1.87M2.24M
Interest Expense25.74M12.89M16.5M12.09M3.59M
Other Income / Expenses(26.47M)(17.44M)(14.27M)(10.53M)(7.19M)
Income Before Tax50.89M17.5M52.32M51.11M40.28M
Pre-Tax Margin12.8%4.1%11.7%15.4%15.6%
Income Tax Expense4.4M5.21M8.33M(5.69M)5.06M
Net Income15.5M(4.41M)18.5M73.49M21.08M
Net Margin3.9%-1.0%4.2%22.2%8.2%
EPS (Basic)1.500.420.731.031.09
EPS (Diluted)1.490.420.731.031.09
Weighted Avg Shares31.09M29.37M25.35M18.5M19.48M
Weighted Avg Shares (Diluted)31.13M29.37M25.25M24M19.48M

Medical Facilities Corporation

TSX:DR.TO

Intrinsic Alpha fair value

Locked

Current Price

$17.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.